Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating

6 3 月, 2026

One Min Read

12 Views

原文: https://finance.yahoo.com/news/truist-raises-price-target-bridgebio-152052020.html

Last Update: 6 3 月, 2026

Written By

Other Articles

Previous

H.C. Wainwright Lowered Its Price Target on SoundHound AI, Inc. (SOUN) to $20 and Maintains a Buy Rating

Next

Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept